Android app Apple app link

Keros Therapeutics, Inc. (KROS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.87
Day's range
$11.56

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/04/2026 Wells Fargo Benjamin Burnett $18.00 $10.11   78.04%
08/04/2026 H.C. Wainwright Andrew Fein $20.00 $10.11   97.82%
11/05/2024 Jefferies Kelly Shi $107.00 $62.02   72.52%
11/05/2024 Truist Financial Srikripa Devarakonda $100.00 $62.02   61.24%
09/22/2024 Guggenheim Vamil Divan $96.00 $55.80   72.04%
06/18/2024 Piper Sandler Joseph Catanzaro $105.00 $44.65   135.16%
05/18/2022 Piper Sandler Joseph Catanzaro $120.00 $39.92   200.6%

Keros Therapeutics Inc FAQ's

Keros Therapeutics Inc has been rated by research analysts at Wells Fargo, H.C. Wainwright, Leerink Partners, Jefferies, Truist Financial, Guggenheim in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.